fda warning compounded peptides bpc 157 tb 500 not approved scientists flag concerns with as RFK Jr. tries to ease access : NPR FDA to weigh easing limits

Physicians generally prescribe 1 cc per week injected intramuscularly

Protocols lasting 812 weeks show measurably better tissue outcomes when injection timing aligns with researcher workflow patterns that ensure zero missed doses, compared to theoretically optimal but inconvenient schedules that introduce gaps

Addendum J to this final rule with comment period includes the cost statistics for each code combination that would qualify for a complexity adjustment (including primary code and add-on code combinations)

The injection is typically administered intramuscularly by a healthcare professional

One literature review paper describes the efficacy of peptides and states that of the available research on BPC 157: [A]ll studies investigating BPC 157 have demonstrated consistently positive and prompt healing effects for various injury types, both traumatic and systemic and for a plethora of soft tissues